Exegenesis Bio, a clinical stage global gene therapy company is pleased to announce that US FDA has granted Orphan Drug Designation ("ODD") to EXG110, a novel gene therapy for Fabry disease, a rare ...

Pathways to new treatments for heart failure take time -; as long as four decades for two now accepted therapies. So, new attempts to repair scar tissue in infarcted hearts using cells or cell ...

Algorae Pharmaceuticals says its new AI-168 drug candidate shows early potential to improve on treatments to protect the ...

Spinach isn’t just good for your diet—it’s revolutionizing heart medicine. Discover how scientists are transforming leafy ...

Combining stem cells and silicon nanowires in lab-grown tissue has shown promise as a step toward a new treatment for heart ...

Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...

New research shows aging is not a uniform process. Parts of our bodies start aging earlier than others, right down to our organs and cells.

Discover how heart pumps enhance muscle regeneration in failed hearts, offering new hope for heart failure patients.

Now in its 30th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, ...

Popular weight loss drugs like Ozempic and Wegovy are showing incredible short-term benefits – from boosted metabolic health ...

Cardiac stem cell therapy with ... However, in our patients, immunomagnetic cell processing was not associated with the induction of human anti-mouse antibodies. 6 In addition, we have addressed ...

Weight-loss drugs making headlines for shrinking waistlines may also be shrinking the human heart and other muscles, reports ...